Assignee
VIVASOR INC
US·3 granted patents·8 pending applications·1 citations·filing 2020–2024
Top patents by PatentIndex Score
11 records- 0176US12064582B2Composite microneedle array including nanostructures thereonVIVASOR INC·Filed 2020·Granted Aug 20, 2024·0 cites·8 claims
- 0273US12029725B2Method for treating osteoarthritis pain by administering resiniferatoxinVIVASOR INC·Filed 2020·Granted Jul 9, 2024·1 cites·18 claims
- 0368US12138415B2Increased bioavailability of transdermally delivered agentsVIVASOR INC·Filed 2020·Granted Nov 12, 2024·0 cites·32 claims
- 0464US2025161261A1Method for Treating Osteoarthritis Pain by Administering ResiniferatoxinVIVASOR INC·Filed 2024·Application pending·0 cites
- 0563US2026069713A1Lipid-Coated NanoparticlesVIVASOR INC·Filed 2023·Application pending·0 cites
- 0662US2025205350A1Antibody-Drug Conjugates and Uses ThereofVIVASOR INC·Filed 2023·Application pending·0 cites
- 0761US2025120905A1Therapeutic agents targeting the lymphatic systemVIVASOR INC·Filed 2022·Application pending·0 cites
- 0859US2026007612A1Novel Ionizable Cationic LipidsVIVASOR INC·Filed 2023·Application pending·0 cites
- 0958US2024279339A1Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery deviceVIVASOR INC·Filed 2022·Application pending·0 cites
- 1053US2025319059A1Method for Treating Inflammatory Dysfunction of the Oral MucosaVIVASOR INC·Filed 2023·Application pending·0 cites
- 1153US2026007747A1Engineered PD-L1-Targeting Gamma Delta T Cell ReceptorsVIVASOR INC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →